Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biologics
Biotech
Regeneron shares updated data on hearing loss gene therapy
Regeneron posted updated clinical data on DB-OTO, providing more evidence of the gene therapy’s potential to treat a rare genetic form of deafness.
Nick Paul Taylor
Oct 12, 2025 10:18am
Novo ends all cell therapy R&D, lets go of staff
Oct 10, 2025 3:30pm
Cabaletta's CAR-T wipes out B cells with no preconditioning
Oct 10, 2025 11:11am
BMS inks $1.5B deal to pull Orbital into its sphere of influence
Oct 10, 2025 8:45am
AviadoBio secures option to rare eye disease gene therapy
Oct 9, 2025 8:50am
ARPA-H goes all in on in vivo cell therapy
Oct 8, 2025 4:04pm
